We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Improved Use of Antibiotic Guidelines in Hospital Environment

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00512772
First Posted: August 8, 2007
Last Update Posted: December 20, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Katholieke Universiteit Leuven
  Purpose
The purpose of this study is to determine if the use of antibiotic guidelines and thus antibiotics can be improved through a description of possible barriers leading to tailored interventions.

Condition
Community-Acquired Pneumonia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Improved Use of Antibiotic Guidelines in in Hospital Environment: Research on an Implementation Model and the Role of the Hospital Pharmacist.

Resource links provided by NLM:


Further study details as provided by Katholieke Universiteit Leuven:

Enrollment: 823
Study Start Date: October 2007
Study Completion Date: July 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients admitted to the hospital with a diagnosis of community-acquired pneumonia or community-acquired pyelonephritis
Criteria

Inclusion Criteria:

  • Diagnosed community-acquired pneumonia (CAP)
  • Diagnosed community-acquired pyelonephritis

Exclusion Criteria:

  • CAP: hospital-acquired pneumonia; patients transferred from other hospital; death within 24h, aspiration pneumonia, immunocompromised status, palliative status, admission due to social reasons
  • Pyelonephritis: urinary tract with functional or physical abnormalities, urinary catheterisation, pregnancy, (immunocompromised status, palliative status, admission due to social reasons and history of renal transplant.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00512772


Locations
Belgium
Ziekenhuis Oost-Limburg
Genk, Belgium, 3600
Universitair Ziekenhuis Gasthuisberg
Leuven, Belgium, 3000
Sponsors and Collaborators
Katholieke Universiteit Leuven
Investigators
Principal Investigator: Pieter-Jan Cortoos, PharmD Katholieke Universiteit Leuven
Study Director: Gert Laekeman, PhD Katholieke Universiteit Leuven
  More Information

Responsible Party: Pieter-Jan Cortoos, PharmD, Katholieke Universiteit Leuven
ClinicalTrials.gov Identifier: NCT00512772     History of Changes
Other Study ID Numbers: B32220072383
First Submitted: August 7, 2007
First Posted: August 8, 2007
Last Update Posted: December 20, 2010
Last Verified: July 2010

Keywords provided by Katholieke Universiteit Leuven:
Time series
Implementation

Additional relevant MeSH terms:
Pneumonia
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Anti-Bacterial Agents
Anti-Infective Agents